BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 14499770)

  • 1. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation.
    Fisher RS; Bromer MQ; Thomas RM; Cohen S; Krevsky B; Horwitz B; Glazier KD; Das K; Das KM
    Am J Gastroenterol; 2003 Sep; 98(9):1945-51. PubMed ID: 14499770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.
    Weston AP; Sharma P
    Am J Gastroenterol; 2002 Dec; 97(12):2998-3006. PubMed ID: 12492182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.
    Pouw RE; Gondrie JJ; Rygiel AM; Sondermeijer CM; ten Kate FJ; Odze RD; Vieth M; Krishnadath KK; Bergman JJ
    Am J Gastroenterol; 2009 Jun; 104(6):1366-73. PubMed ID: 19491850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balloon-based electrode for the ablation of non-dysplastic Barrett's esophagus: ablation of intestinal metaplasia (AIM II Trial).
    Avilés A; Reymunde A; Santiago N
    Bol Asoc Med P R; 2006; 98(4):270-5. PubMed ID: 19610568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?
    Morales TG; Bhattacharyya A; Johnson C; Sampliner RE
    Am J Gastroenterol; 1997 Oct; 92(10):1818-22. PubMed ID: 9382043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy.
    Byrne JP; Bhatnagar S; Hamid B; Armstrong GR; Attwood SE
    Am J Gastroenterol; 1999 Jan; 94(1):98-103. PubMed ID: 9934738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
    Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
    Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
    Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
    Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction.
    Kamberoglou DK; Savva SC; Kalapothakos PN; Koukounas ND; Doulgeroglou VG; Patra EG; Tzias VD
    Hepatogastroenterology; 2002; 49(46):995-8. PubMed ID: 12143262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of short segment Barrett's esophagus with intestinal metaplasia in stomach.
    Tuncer I; Ugraş S; Uygan I; Türkdoğan K; Kösem M
    Turk J Gastroenterol; 2003 Mar; 14(1):33-8. PubMed ID: 14593535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
    Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence.
    Ferraris R; Fracchia M; Foti M; Sidoli L; Taraglio S; Vigano' L; Giaccone C; Rebecchi F; Meineri G; Senore C; Pera A;
    Aliment Pharmacol Ther; 2007 Apr; 25(7):835-40. PubMed ID: 17373922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy.
    Amano Y; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Ishimura N; Furuta K; Ishihara S; Adachi K; Maruyama R; Kinoshita Y
    J Gastroenterol Hepatol; 2007 Jun; 22(6):901-7. PubMed ID: 17565646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus.
    Hiraoka S; Mizuno M; Nasu J; Okazaki H; Makidono C; Okada H; Terada R; Yamamoto K; Fujita T; Shiratori Y
    J Lab Clin Med; 2004 Apr; 143(4):201-6. PubMed ID: 15085078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.